Evidence map›Paper›PMID 39109433›Full record

ArticleFuture medicinal chemistry2024

Palbociclib-derived multifunctional molecules for lysosomal targeting and diagnostic-therapeutic integration.

Haili Yang, Xiaoyang Zhang, Letian Xu, Yuting Zhou, Rui Ma, Hao Chen, Siqin Zhao, Munkhtsetseg Baatar, Lvyi Chen, Xukun Deng and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Haili YangState Key Laboratory of Pharmaceutical Biotechnology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, School of Life Sciences, Nanjing University, Nanjing, 210023P. R. China.
Xiaoyang ZhangCentral Laboratory, Nanjing Integrated Traditional Chinese & Western Medicine Hospital Affiliated with Nanjing University of Chinese Medicine, Nanjing, 210014P. R. China.
Letian XuState Key Laboratory of Pharmaceutical Biotechnology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, School of Life Sciences, Nanjing University, Nanjing, 210023P. R. China.
Yuting ZhouState Key Laboratory of Pharmaceutical Biotechnology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, School of Life Sciences, Nanjing University, Nanjing, 210023P. R. China.
Rui MaState Key Laboratory of Pharmaceutical Biotechnology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, School of Life Sciences, Nanjing University, Nanjing, 210023P. R. China.
Hao ChenState Key Laboratory of Pharmaceutical Biotechnology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, School of Life Sciences, Nanjing University, Nanjing, 210023P. R. China.
Siqin ZhaoCollege of Chemistry & Environmental Science, Inner Mongolia Normal University, Hohhot, 010022P. R. China.
Munkhtsetseg BaatarChemistry Department, Ulaanbaatar State University, Bayanzurkh district, Ulaanbaatar, Mongolia.
Lvyi ChenSchool of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, 430074P. R. China.
Xukun DengSchool of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, 430074P. R. China.
Hongwei GuCentral Laboratory, Nanjing Integrated Traditional Chinese & Western Medicine Hospital Affiliated with Nanjing University of Chinese Medicine, Nanjing, 210014P. R. China.
Xiaoming WangState Key Laboratory of Pharmaceutical Biotechnology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, School of Life Sciences, Nanjing University, Nanjing, 210023P. R. China.ORCID 0000-0003-4559-7413

Funding

Project supported by Medical Science and technology development Foundation, Jiangsu Commission of Health H2019085Project supported by Nanjing medical science and technology development fund YKK21190
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsLysosomesPiperazinesPyridinesCell Line, TumorCell ProliferationCyclin-Dependent Kinase 4Fluorescein-5-isothiocyanateFluorescent DyesHumansHydrogen-Ion ConcentrationMolecular StructureAntineoplastic AgentsCyclin-Dependent Kinase 4Fluorescein-5-isothiocyanateFluorescent DyespalbociclibPiperazinesPyridinesanticancer druglysosome-targeted imagingpH monitoring

Identifiers

PMID39109433
PMCPMC11318731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.